The Kentucky Senate has passed Senate Bill (SB) 14, sponsored by Leitchfield Republican Sen. Steven Meredith, to help ensure Kentucky hospitals, pharmacies and healthcare providers receive fair access to discounted drug pricing under the federal 340B program.
“The 340B Drug Pricing Program, a federal initiative, requires pharmaceutical manufacturers to sell outpatient drugs at reduced prices to eligible healthcare facilities that serve low-income and underserved populations. However, in recent years, some drug manufacturers have imposed unnecessary restrictions, making it harder for Kentucky’s hospitals, community health centers, and rural clinics to access these critical savings,” Meredith’s office said.
SB 14 ensures Kentucky providers receive equal treatment by preventing manufacturers from denying or restricting 340B drug pricing if they offer the same discounts in other states, according to Meredith. This protection helps healthcare providers reduce drug costs and reinvest savings into patient care, expanding access to affordable medications across the commonwealth.
“Access to affordable medication is essential for the health and sustainability of our communities, especially in rural areas where providers operate on tight margins,” Meredith said. “Hospitals and pharmacies in Kentucky should not face unnecessary barriers to the cost-saving benefits of the 340B program. This bill ensures fairness, allowing our healthcare providers to reinvest savings into patient care and continue serving those who rely on them most. I am pleased to see SB 14 pass the Senate and look forward to working with my colleagues in the House to get this important legislation across the finish line.”
The bill also empowers the Kentucky attorney general to investigate violations, ensuring that drug companies comply with fair pricing rules.
The bill does not mandate or expand specific healthcare services but instead reinforces Kentucky’s commitment to fair drug pricing and protecting access to affordable medications for vulnerable communities.
SB 14 now moves to the Kentucky House for its consideration.
For more information about SB 14 or to follow its progress through the 2025 Kentucky General Assembly, visit www.legislature.ky.gov.
By Ken Howlett, News Director
Contact Ken at ken@k105.com
